DrCarney.com Blog
Intestinal microbiota metabolism and atherosclerosis.
Trimethylamine-N-oxide (TMAO), a metabolite produced by intestinal microbes, is associated with elevated atherosclerosis and cardiovascular disease risk.
This study evaluated the association between the metabolic activity of intestinal microbes and cardiovascular disease (CVD) risk. Researchers analyzed data obtained from several published literatures on the subject. They found out that trimethylamine-N-oxide (TMAO)—an organic compound produced from the metabolism of foods that contain trimethylamine (TMA) by intestinal microbes—had pro-atherogenic activity, promoting the development of atherosclerosis and other cardiovascular diseases. The findings of this meta-analysis strengthen the hypothesis that high intestinal microbial metabolism of TMA-containing compounds may increase the likelihood of developing atherosclerosis and other cardiovascular ailments.
Research Summary Information
-
2015
-
Liu TX, Niu HT, Zhang SY.
-
Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
-
Yes, Free full text of study was found:
When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.
About the author
